Intalight Secures CE Mark for Revolutionary DREAM OCT Imaging Technology in Ophthalmology

Intalight Secures CE Mark for Revolutionary DREAM OCT Imaging Technology



In a significant advancement for the field of ophthalmology, Intalight™, a pioneering company in ophthalmic technologies, has proudly announced the receipt of the CE mark for their innovative product, the DREAM OCT™. This approval from the European Union marks a pivotal moment for the company and the ophthalmic community, allowing for the commercialization of cutting-edge imaging technology that promises to enhance patient care across Europe.

The Significance of CE Mark Approval



The CE mark serves as an assurance of compliance with EU safety and performance standards. For Intalight, this achievement validates their commitment to develop state-of-the-art technology, enabling eye care professionals across Europe to provide improved diagnostic and treatment services. Shawn Peng, Intalight's founder and chairman, expressed his pride at this milestone, stating, "This achievement allows us to provide ophthalmologists in Europe with state-of-the-art technology that delivers improved results for their patients."

The Innovative Features of DREAM OCT



The DREAM OCT platform, which stands for Deep imaging depth, Rapid sweeping speed, Extensive scan range, Accurate results, and Multimodal imaging capabilities, represents the latest evolution in Optical Coherence Tomography (OCT) technologies. It delivers superior quality OCT images and is designed to tackle the most demanding imaging challenges faced by retina specialists and comprehensive ophthalmologists.

DREAM OCT enables an impressive 130° single shot OCTA image, promising a comprehensive view with unmatched accuracy. The platform's unique swept-source technology allows for 12 mm super-depth scanning, permitting superior imaging of the retina, choroid, and significantly large portions of the vitreous space. The advanced scanning capability also ensures that the entire anterior segment, from the cornea to the anterior part of the vitreous, can be captured in a single sweep.

Addressing the Needs of Eye Care Professionals



In today’s fast-paced healthcare environment, speed and precision are paramount. The need for a robust imaging solution that meets the evolving demands of professionals in the field is more critical than ever. Bing Li, CEO and co-founder of Intalight, emphasized this necessity, noting that DREAM OCT was crafted in response to feedback from eye care experts seeking enhanced imaging modalities. "DREAM OCT delivers a complete set of imaging modalities for the most challenging clinical and research applications for the retina and outperforms everything else HCPs know," he stated.

Research and Collaboration at the Forefront



The DREAM OCT technology has already made considerable impacts, with over 160 peer-reviewed studies based on its results. This highlights the device's importance not only in clinical practice but in advancing research within the ophthalmic community. Intalight remains dedicated to collaborating with leading academic institutions and private practices globally, enhancing dialogue between clinical application and research advancements.

The CEO of Intalight expressed excitement at this development, saying, "This is such exciting news for Intalight that there's no more waiting in Europe, and we look forward to being able to provide this innovative solution in the US." As the company anticipates FDA approval, they are poised to expand their reach in the ophthalmic market.

About Intalight



Founded by a team of scientists and industry veterans from Silicon Valley, Intalight Inc. is committed to developing next-generation ophthalmic technologies. The company now operates from three sites: Silicon Valley, Shanghai, and Luoyang. Through the creation of the DREAM OCT imaging device, Intalight has integrated deep imaging depth, rapid sweeping speed, an extensive scanning range, accurate lesion detection, and multi-modal imaging capabilities—fundamental features that are reshaping daily clinical practices and allowing for groundbreaking research.

For more insights into Intalight and its pioneering technologies, visit their official website at www.intalight.com and connect with them on social media platforms.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.